Investing in Stocks

5 Best Health and Wellness Stocks for a Growing Industry

Published

2 months ago

May 6, 2024

Securities.io is not an investment adviser, and this does not constitute investment advice, financial advice, or trading advice. Securities.io does not recommend that any security should be bought, sold, or held by you. Conduct your own due diligence and consult a financial adviser before making any investment decisions.

Whether mental or physical, one's approach to health and wellness is crucial to ensuring a long and happy life; this is true for all ages, regardless of where you are from. Recognizing this, it is clear that there is a widespread need for solutions addressing health and wellness, with the following companies' examples of doing just that.

Before investing, make sure to research the role of a broker and what one can do for you.

Health and Wellness Companies

Before diving into our list, note that our look at health and wellness companies extends to include those offering products and services for not just the body, but the mind as well.

*Figures provided below were accurate at the time of writing and are subject to change. Any potential investor should verify metrics*

1. COMPASS Pathways plc

Market Cap	Forward P/E 1 Yr.	Earnings Per Share(EPS)
398,733,483	-3.55	$-2.39

COMPASS Pathways is a mental health company that maintains a strong focus on the development of forward-thinking therapies. The most prominent of these is its use of synthetic psilocybin in psychedelic therapies meant to address and ease symptoms associated with treatment-resistant depression (TRD). To date, the company has conducted one of the largest psilocybin therapy trials for depression, as it aims to standardize doses within therapeutic settings.

Impressively, the company has already established various strategic partnerships with companies like Thermo Fisher Scientific, and the Southwest Research Institute, all while it navigates a tricky regulatory landscape.

Investing in COMPASS Pathways is particularly intriguing due to its innovative approach to treating severe depression—a condition poorly addressed by current medications— resulting in substantial market potential, given the high prevalence and need for effective treatments. Between shifting medical and societal perspectives towards psychedelics, coupled with regulatory clarity and its potential first-mover advantage in this new therapeutic category, COMPASS Pathways makes a particularly compelling stock in the field of psychedelic medicine.

At the time of writing, CMPS was listed by the majority of analysts as a ‘Strong Buy'.

2. Mind Medicine (MindMed) Inc.

Market Cap	Forward P/E 1 Yr.	Earnings Per Share(EPS)
409,622,982	-5.81	$-2.45

Mind Medicine, or ‘MindMed,' is another company at the forefront of developing psychedelic-inspired medicines. Like COMPASS Pathways, it maintains a focus on addressing mental health issues such as anxiety, depression, and addiction. Its approach sees that the company explores the therapeutic potential of substances like LSD, MDMA, and psilocybin in controlled clinical environments.

Notably, the company is already engaged in multiple Phase II trials. These trials aim to unlock new treatments hoped to revolutionize current approaches and treatments for the aforementioned mental health disorders. By integrating cutting-edge science with stringent regulatory strategies, MindMed seeks to ensure safety and efficacy, positioning itself as a leader in the nascent field of psychedelic medicine.

MindMed's stock is worthy of consideration due to its pioneering research into compounds historically marginalized in the medical community. With a growing body of evidence supporting the therapeutic benefits of psychedelics, the company is already well-placed to capitalize on increasing acceptance and potential legalization of these substances for medical use. The company’s potential to lead in this field and the health and wellness sector at large make it a noteworthy and promising stock to follow.

At the time of writing, MNMD was listed by the majority of analysts as a ‘Strong Buy‘.

3. Teladoc Health, Inc.

Market Cap	Forward P/E 1 Yr.	Earnings Per Share(EPS)
2,180,903,879	-12.29	$-1.41

Based in the United States, Teladoc Health is a leader in virtual healthcare services. As its name would imply, it offers a wide range of medical services via telecommunication technologies. These include solutions that allow patients to receive healthcare remotely, such as general medical consultations, as well as specialized areas, such as mental health, chronic condition management, and medical opinions.

Over the past few years, Teladoc Health has expanded rapidly through the acquisition of companies, including Livongo Health, in 2020, enhancing its ability to manage chronic diseases with data-driven insights.

Teladoc Health is an appealing investment for several reasons. Firstly, the COVID-19 pandemic dramatically accelerated the adoption of telehealth services, establishing a new norm in how medical care is delivered and received. As a result, Teladoc saw its potential market grow rapidly. Secondly, its platform, which combines a broad spectrum of health services, should position it as a key player within its respective industry. Notably, the Teledoc Health platform is in the midst of an ongoing integration with AI. This integration will see machine learning leveraged in an attempt to personalize care more effectively, all the while improving the efficiency of its operations. Overall, as healthcare continues to evolve towards more accessible and technology-driven solutions, Teladoc's role and expansive reach in telehealth make it a compelling stock for those looking to invest in the future of healthcare delivery.

At the time of writing, TDOC was listed by the majority of analysts as a ‘Buy‘.

4. Peloton Interactive, Inc.

Market Cap	Forward P/E 1 Yr.	Earnings Per Share(EPS)
1,314,536,906	-2.13	$-2.11

Peloton Interactive remains a prominent player in the interactive fitness equipment and media industry. While it is primarly known for its luxury stationary bicycles and treadmills that integrate live and on-demand fitness classes, the company has continued to expand its product line since going public in 2019. This has seen the launch of various high-end fitness equipment, and a subscription-based exercise class platform that streams workouts directly to users' equipment or devices.

Peloton Interactive stock is worth consideration for multiple reasons. Firstly, it has managed to successfully build a following around its innovative blending of fitness and technology, which has redefined home workouts. Secondly, there may have been an overcorrection after the pandemic, which saw shares in Peleton plummet as people went back to work and gyms re-opened. While it may not have been able to sustain the growth it saw during the pandemic, Peloton's efforts to expand its product offerings, enter new markets, and adjust its pricing models have done well to highlight its adaptability. Furthermore, its strong brand loyalty and the continued trend towards health and wellness are positive indicators of its long-term potential. Peloton's ability to innovate in both product development and content delivery makes it a compelling option for investors interested in the convergence of fitness, technology, and media.

At the time of writing, PTON was listed by the majority of analysts as a ‘Buy‘.

5. The Simply Good Foods Company

Market Cap	Forward P/E 1 Yr.	Earnings Per Share(EPS)
3,696,592,073	21.84	$1.39

The Simply Good Foods Company is a consumer packaged goods company in North America, primarily known for its offerings under the Atkins and Quest Nutrition brands. These brands focus on producing and marketing nutritional products and snacks that align with a low-carbohydrate eating approach. The company's products, which include protein bars, shakes, and frozen meals, cater to consumers pursuing healthier dietary choices and lifestyles.

The Simply Good Foods Company could be a timely play, as an increased and growing focus in being placed on health-conscious eating worldwide. This rising awareness and consumer demand for nutritional content transparency and low-carb diets provide a solid growth platform for the company. In addition, its strong brand recognition, particularly with Atkins and Quest, allows it to leverage brand loyalty to expand its customer base.

As more consumers opt for healthier snacking and meal options, The Simply Good Foods Company's focus on quality and nutrition makes it a potentially valuable investment in the expanding health and wellness industry.

At the time of writing, SMPL was listed by the majority of analysts as a ‘Strong Buy‘.